Analyst Ratings for Calidi Biotherapeutics Inc (CLDI)

CLDI Rating Summary

  |   Expand Research on CLDI
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/27/2024 Rodman & Renshaw N/A New Coverage Buy
(N/A)		 1.00
(N/A)		 0.20
(0.15)		 -25% Details
6/27/2024 Ladenburg Thalmann Aydin Huseynov New Coverage Buy
(N/A)		 1.00
(N/A)		 0.20
(0.15)		 -25% Details